Literature DB >> 1531293

Low dose ondansetron and dexamethasone: a cost effective alternative to high dose metoclopramide/dexamethasone/lorazepam in the prevention of acute cisplatin induced emesis.

R Sands, J T Roberts, M Marsh, A Gill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1531293     DOI： 10.1016/s0936-6555(05)80784-8

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  2 in total

1.  Cost and cost-effectiveness analysis of ondansetron versus metoclopramide regimens: a hospital perspective from Italy.

Authors:  E Ballatori; F Roila; P Berto; V De Angelis; C Neri; A Olivieri; M Tonato; A Del Favero
Journal:  Pharmacoeconomics       Date:  1994-03       Impact factor: 4.981

Review 2.  Ondansetron: a pharmacoeconomic and quality-of-life evaluation of its antiemetic activity in patients receiving cancer chemotherapy.

Authors:  G L Plosker; R J Milne
Journal:  Pharmacoeconomics       Date:  1992-10       Impact factor: 4.981
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.